Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors.

Nature immunology | May 29, 2004

Activation of Toll-like receptors (TLRs) results in a proinflammatory response needed to combat infection. Thus, limiting TLR signaling is essential for preventing a protective response from causing injury to the host. Here we describe how a RING finger protein, Triad3A, acts as an E3 ubiquitin-protein ligase and enhances ubiquitination and proteolytic degradation of some TLRs. Triad3A overexpression promoted substantial degradation of TLR4 and TLR9 with a concomitant decrease in signaling, but did not affect TLR2 expression or signaling. Conversely, a reduction in endogenous Triad3A by small interfering RNA increased TLR expression and enhanced TLR activation. Thus, ubiquitination by Triad3A represents one pathway by which the intensity and duration of TLR signaling is controlled.

Pubmed ID: 15107846 RIS Download

Mesh terms: Amino Acid Sequence | Carrier Proteins | Humans | Intracellular Signaling Peptides and Proteins | Membrane Glycoproteins | Molecular Sequence Data | Receptors, Cell Surface | Toll-Like Receptor 2 | Toll-Like Receptor 4 | Toll-Like Receptor 9 | Toll-Like Receptors | Ubiquitin-Protein Ligases

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, Id: AI15136
  • Agency: NIAID NIH HHS, Id: AI54523
  • Agency: NIGMS NIH HHS, Id: GM28485

BioGRID (Data, Interactions)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.